Photo of Richard T. Maziarz, MD

Richard T. Maziarz MD

Dr. Maziarz specializes in treating bone marrow transplantation and blood cancers. His research interests cover how the immune system recovers after a bone marrow transplant and how the immune system works to fight cancer. Dr. Maziarz sees patients with leukemia, lymphoma and graft vs. host disease and patients who are being treated with immune system therapies.

Education

  • M.D., Harvard Medical School, 0 0 1979
  • Residency:

    • University Hospitals of Cleveland, 1981
  • Fellowship:

    • Immunology, Dana-Farber Cancer Institute, 1985
  • Certifications:

    • American Board of Internal Medicine (internal medicine), 1982

Memberships and associations

  • American Society of Hematology

Publications

  • "Who with chronic myelogenous leukemia to transplant in the era of tyrosine kinase inhibitors?" Current Opinion in Hematology March 2008
  • "No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation" Transplant Infectious Disease October 2012
  • "Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII" Cytotherapy  2014
  • "Regulation of cytotoxic T lymphocyte-mediated graft rejection following bone marrow transplantation" Transplantation  1988
  • "Transplantation for CML" Blood May 15 2006
  • "Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria" British Journal of Haematology  2001
  • "Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia" Biology of Blood and Marrow Transplantation  2014
  • "Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells" Cytotherapy  2008
  • "Novel H1N1 Influenza in Hematopoietic Stem Cell Transplantation Recipients" Biology of Blood and Marrow Transplantation April 2011
  • "Outcomes of Hematologic Malignancies after Unrelated Donor Hematopoietic Cell Transplantation According to Place of Residence" Biology of Blood and Marrow Transplantation March 2010
  • "Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma" Bone Marrow Transplantation June 2013
  • "Successful Stem Cell Remobilization Using Plerixafor (Mozobil) Plus Granulocyte Colony-Stimulating Factor in Patients with Non-Hodgkin Lymphoma" Biology of Blood and Marrow Transplantation December 2009
  • "Non-MHC-restricted target-cell lysis by a CD4-CD8- TCRαβ T-cell line, as well as by TCRγδ T-cell lines, results from lymphokine-activated killing" International Journal of Cancer  1991
  • "HLA DR15 Antigen Status Does Not Impact Graft-versus-Host Disease or Survival in HLA-Matched Sibling Transplantation for Hematologic Malignancies" Biology of Blood and Marrow Transplantation August 2012
  • "Unrelated donor transplants in adults with philadelphia-negative acute lymphoblastic leukemia in first complete remission" Blood July 15 2008
  • "Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate" Leukemia March 1 2003
  • "Induction bortezomib in AL amyloidosis followed by high dose melphalan and autologous stem cell transplantation" Clinical Lymphoma, Myeloma and Leukemia October 1 2014
  • "Phase II Trial of Parathyroid Hormone after Double Umbilical Cord Blood Transplantation" Biology of Blood and Marrow Transplantation December 2012
  • "Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents" Biology of Blood and Marrow Transplantation  2014
  • "Standardization of terminology for episodes of hematopoietic stem cell patient transplant care" Biology of Blood and Marrow Transplantation June 2013
  • "Explaining family caregiver role strain following autologous blood and marrow transplantation" Journal of Psychosocial Oncology September 15 2006
  • "Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease" Blood September 1 2004
  • "Increased incidence of cytomegalovirus disease after autologous CD34- selected peripheral blood stem cell transplantation" Blood December 15 1999
  • "TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements" Blood January 8 2009
  • "Autologous stem cell transplantation for Hodgkin's disease" Bone Marrow Transplantation August 2003
  • "Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies" Biology of Blood and Marrow Transplantation March 2011
  • "Specific immunotherapy for non-Hodgkin's lymphoma" Laboratory Medicine  2001
  • "Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure" Journal of Clinical Oncology August 10 2010
  • "High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease" Biology of Blood and Marrow Transplantation November 1997
  • "Overview of hematopoietic stem cell transplantation"   2011

Additional information

Edit profile